Copyright Reports & Markets. All rights reserved.

Global Ensartinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Ensartinib
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ensartinib Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ensartinib Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Ensartinib Market Size & Forecast
    • 1.5.1 Global Ensartinib Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Ensartinib Sales Quantity (2018-2029)
    • 1.5.3 Global Ensartinib Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 BioVision
    • 2.1.1 BioVision Details
    • 2.1.2 BioVision Major Business
    • 2.1.3 BioVision Ensartinib Product and Services
    • 2.1.4 BioVision Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 BioVision Recent Developments/Updates
  • 2.2 Cayman Chemical
    • 2.2.1 Cayman Chemical Details
    • 2.2.2 Cayman Chemical Major Business
    • 2.2.3 Cayman Chemical Ensartinib Product and Services
    • 2.2.4 Cayman Chemical Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Cayman Chemical Recent Developments/Updates
  • 2.3 LifeSpan BioSciences
    • 2.3.1 LifeSpan BioSciences Details
    • 2.3.2 LifeSpan BioSciences Major Business
    • 2.3.3 LifeSpan BioSciences Ensartinib Product and Services
    • 2.3.4 LifeSpan BioSciences Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 LifeSpan BioSciences Recent Developments/Updates
  • 2.4 Selleck Chemicals
    • 2.4.1 Selleck Chemicals Details
    • 2.4.2 Selleck Chemicals Major Business
    • 2.4.3 Selleck Chemicals Ensartinib Product and Services
    • 2.4.4 Selleck Chemicals Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Selleck Chemicals Recent Developments/Updates
  • 2.5 AbMole
    • 2.5.1 AbMole Details
    • 2.5.2 AbMole Major Business
    • 2.5.3 AbMole Ensartinib Product and Services
    • 2.5.4 AbMole Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AbMole Recent Developments/Updates
  • 2.6 Biorbyt
    • 2.6.1 Biorbyt Details
    • 2.6.2 Biorbyt Major Business
    • 2.6.3 Biorbyt Ensartinib Product and Services
    • 2.6.4 Biorbyt Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Biorbyt Recent Developments/Updates
  • 2.7 LKT Laboratories
    • 2.7.1 LKT Laboratories Details
    • 2.7.2 LKT Laboratories Major Business
    • 2.7.3 LKT Laboratories Ensartinib Product and Services
    • 2.7.4 LKT Laboratories Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 LKT Laboratories Recent Developments/Updates
  • 2.8 BOC Sciences
    • 2.8.1 BOC Sciences Details
    • 2.8.2 BOC Sciences Major Business
    • 2.8.3 BOC Sciences Ensartinib Product and Services
    • 2.8.4 BOC Sciences Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 BOC Sciences Recent Developments/Updates
  • 2.9 Target Molecule
    • 2.9.1 Target Molecule Details
    • 2.9.2 Target Molecule Major Business
    • 2.9.3 Target Molecule Ensartinib Product and Services
    • 2.9.4 Target Molecule Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Target Molecule Recent Developments/Updates
  • 2.10 MuseChem
    • 2.10.1 MuseChem Details
    • 2.10.2 MuseChem Major Business
    • 2.10.3 MuseChem Ensartinib Product and Services
    • 2.10.4 MuseChem Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 MuseChem Recent Developments/Updates
  • 2.11 Wuhan Sun-Shine Bio-Technology
    • 2.11.1 Wuhan Sun-Shine Bio-Technology Details
    • 2.11.2 Wuhan Sun-Shine Bio-Technology Major Business
    • 2.11.3 Wuhan Sun-Shine Bio-Technology Ensartinib Product and Services
    • 2.11.4 Wuhan Sun-Shine Bio-Technology Ensartinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Wuhan Sun-Shine Bio-Technology Recent Developments/Updates

3 Competitive Environment: Ensartinib by Manufacturer

  • 3.1 Global Ensartinib Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Ensartinib Revenue by Manufacturer (2018-2023)
  • 3.3 Global Ensartinib Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Ensartinib by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Ensartinib Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Ensartinib Manufacturer Market Share in 2022
  • 3.5 Ensartinib Market: Overall Company Footprint Analysis
    • 3.5.1 Ensartinib Market: Region Footprint
    • 3.5.2 Ensartinib Market: Company Product Type Footprint
    • 3.5.3 Ensartinib Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ensartinib Market Size by Region
    • 4.1.1 Global Ensartinib Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Ensartinib Consumption Value by Region (2018-2029)
    • 4.1.3 Global Ensartinib Average Price by Region (2018-2029)
  • 4.2 North America Ensartinib Consumption Value (2018-2029)
  • 4.3 Europe Ensartinib Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Ensartinib Consumption Value (2018-2029)
  • 4.5 South America Ensartinib Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Ensartinib Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Ensartinib Sales Quantity by Type (2018-2029)
  • 5.2 Global Ensartinib Consumption Value by Type (2018-2029)
  • 5.3 Global Ensartinib Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Ensartinib Sales Quantity by Application (2018-2029)
  • 6.2 Global Ensartinib Consumption Value by Application (2018-2029)
  • 6.3 Global Ensartinib Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Ensartinib Sales Quantity by Type (2018-2029)
  • 7.2 North America Ensartinib Sales Quantity by Application (2018-2029)
  • 7.3 North America Ensartinib Market Size by Country
    • 7.3.1 North America Ensartinib Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Ensartinib Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Ensartinib Sales Quantity by Type (2018-2029)
  • 8.2 Europe Ensartinib Sales Quantity by Application (2018-2029)
  • 8.3 Europe Ensartinib Market Size by Country
    • 8.3.1 Europe Ensartinib Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Ensartinib Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ensartinib Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Ensartinib Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Ensartinib Market Size by Region
    • 9.3.1 Asia-Pacific Ensartinib Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Ensartinib Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Ensartinib Sales Quantity by Type (2018-2029)
  • 10.2 South America Ensartinib Sales Quantity by Application (2018-2029)
  • 10.3 South America Ensartinib Market Size by Country
    • 10.3.1 South America Ensartinib Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Ensartinib Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ensartinib Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Ensartinib Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Ensartinib Market Size by Country
    • 11.3.1 Middle East & Africa Ensartinib Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Ensartinib Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Ensartinib Market Drivers
  • 12.2 Ensartinib Market Restraints
  • 12.3 Ensartinib Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ensartinib and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ensartinib
  • 13.3 Ensartinib Production Process
  • 13.4 Ensartinib Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ensartinib Typical Distributors
  • 14.3 Ensartinib Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity.
    According to our (Global Info Research) latest study, the global Ensartinib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Ensartinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Ensartinib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Ensartinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Ensartinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
    Global Ensartinib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ensartinib
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ensartinib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioVision, Cayman Chemical, LifeSpan BioSciences, Selleck Chemicals and AbMole, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Ensartinib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Min Purity Less Than 98%
    Min Purity 98%-99%
    Min Purity More Than 99%
    Market segment by Application
    Research
    Medical
    Major players covered
    BioVision
    Cayman Chemical
    LifeSpan BioSciences
    Selleck Chemicals
    AbMole
    Biorbyt
    LKT Laboratories
    BOC Sciences
    Target Molecule
    MuseChem
    Wuhan Sun-Shine Bio-Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ensartinib product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ensartinib, with price, sales, revenue and global market share of Ensartinib from 2018 to 2023.
    Chapter 3, the Ensartinib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ensartinib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ensartinib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ensartinib.
    Chapter 14 and 15, to describe Ensartinib sales channel, distributors, customers, research findings and conclusion.

    Buy now